Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p

Cisplatin has been used as the first-line chemotherapy to treat advanced nasopharyngeal carcinoma (NPC), while acquired cisplatin resistance resulting from epigenetic regulation is not well understood. The relative expression of LINC00346 was detected in healthy persons, cisplatin-sensitive (CS) pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Zheqing, Pu, Tian, Zhang, Yujie, Wang, Jia, Zhao, Yulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276527/
https://www.ncbi.nlm.nih.gov/pubmed/32397872
http://dx.doi.org/10.1098/rsob.190286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276527/
https://www.ncbi.nlm.nih.gov/pubmed/32397872
http://dx.doi.org/10.1098/rsob.190286

Ejemplares similares